Last reviewed · How we verify
NCT05200117
Pregnolia System Intra-observer Variability
trial testing Pregnolia System in Cervix; Pregnancy in 26 participants. Completed in 17 December 2023.
17 December 2023
Quick facts
| Lead sponsor | Pregnolia AG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 26 |
| Start date | 12 January 2022 |
| Primary completion | 17 December 2023 |
| Estimated completion | 17 December 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Pregnolia System
Conditions studied
- Cervix; Pregnancy — all drugs for Cervix; Pregnancy →
- Cervical Stiffness — all drugs for Cervical Stiffness →
Sponsor
Pregnolia AG
Who can join
Adults 18 to 60, female only, with Cervix; Pregnancy or Cervical Stiffness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Pregnolia System is a CE-marked medical device assessing the mechanical stiffness of cervical tissue in women. The Pregnolia Probe has been engineered to minimize the influence of differences in handling and technique by the user. This project aims to study intra-observer variability of the Pregnolia System in pregnant women in the clinical setting. Furthermore, a same day repeated measurement serves to investigate the time period needed to recover the pre-measurement stiffness state due to viscoelasticity of the cervical tissue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05200117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pregnolia System
Trials testing the same drug.
- NCT05858775 — Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation · completed
Other recruiting trials for Cervix; Pregnancy
Currently open trials in the same condition.
- NCT05246579 — Prospective Evaluation of Pathways for Preterm Birth · recruiting
Other Pregnolia AG trials
Trials by the same sponsor.
- NCT05858775 — Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05200117 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pregnolia AG
- Last refreshed: 29 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05200117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing